EMA Withdrawn: Copiktra (duvelisib) — Secura Bio Limited

View source ↗

Summary

The European Medicines Agency has withdrawn the marketing authorization for Copiktra (duvelisib) from Secura Bio Limited; the drug for chronic lymphocytic leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma

Drugs mentioned

• COPIKTRA (duvelisib)

Snippet

Status: Withdrawn. Therapeutic area: Leukemia, Lymphocytic, Chronic, B-Cell;Lymphoma, Follicular. MAH: Secura Bio Limited. Decision date: 10/08/2023